Grant: Operating Grant
McGill University
$210,140.00
Blood-based protein test for early detection of breast cancer using antibody colocalization microarrays
FY 2012-13
Summary
One in eight women will be diagnosed with cancer during her lifetime, and the earlier the cancer is detected the better the chances of survival.
We propose to develop a new technology that can detect many different proteins associated with cancer in the blood of patients. The technology will be exquisitely sensitive, and will be capable of identifying and quantifying over one hundred different proteins in the blood within a background of unrelated proteins that are up to a trillion times more concentrated. By measuring many proteins simultaneously, we will establish a molecular portrait (or fingerprint) of a person's blood. We will capture protein portraits for a large number of healthy women and cancer patients, and using computational data analysis, compare the portraits between the two groups to identify the molecular signature of breast cancer. This molecular signature will then be tested in a second group of patients and healthy women to confirm its accuracy.
A successful outcome will result in a simple-to-use test to diagnose cancer using a droplet of blood. Such test could be used in combination with mammography, notably for women with dense breasts where it is difficult to detect breast cancer, and where a molecular signature may help confirm or infirm a preliminary diagnosis. In the long term, we envision that this test could be used by family doctors for early diagnosis of breast cancer.
Department
Program
Operating Grant
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
268086
Name
Juncker David
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Cancer Progression & Therapeutics 2
Projecttitle
Blood-based protein test for early detection of breast cancer using antibody colocalization microarrays
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$210,140
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Antibody Microarrays; Biomarkers; Breast Cancer Subtype; Early Diagnosis; Multiplexed Sandwich Immunoassays; Personalized Medicine; Proteomics
Abstract
One in eight women will be diagnosed with cancer during her lifetime, and the earlier the cancer is detected the better the chances of survival.
We propose to develop a new technology that can detect many different proteins associated with cancer in the blood of patients. The technology will be exquisitely sensitive, and will be capable of identifying and quantifying over one hundred different proteins in the blood within a background of unrelated proteins that are up to a trillion times more concentrated. By measuring many proteins simultaneously, we will establish a molecular portrait (or fingerprint) of a person's blood. We will capture protein portraits for a large number of healthy women and cancer patients, and using computational data analysis, compare the portraits between the two groups to identify the molecular signature of breast cancer. This molecular signature will then be tested in a second group of patients and healthy women to confirm its accuracy.
A successful outcome will result in a simple-to-use test to diagnose cancer using a droplet of blood. Such test could be used in combination with mammography, notably for women with dense breasts where it is difficult to detect breast cancer, and where a molecular signature may help confirm or infirm a preliminary diagnosis. In the long term, we envision that this test could be used by family doctors for early diagnosis of breast cancer.
Competitiondate
201209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Juncker, David
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $210,140~ $0~